Skip to main content

Advertisement

Log in

Increased Oxidative Stress and Altered Levels of Nitric Oxide and Peroxynitrite in Tunisian Patients with Chronic Obstructive Pulmonary Disease: Correlation with Disease Severity and Airflow Obstruction

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

This study was aimed to evaluate the oxidant–antioxidant imbalance in the pathogenesis of chronic obstructive pulmonary disease (COPD) in Tunisians. We assessed 16 parameters related to the oxidative status that include malondialdehyde (MDA), total protein carbonyls (PCs), and advanced oxidation protein products (AOPP). We also examined the activity of glutathione peroxydase (GSH-Px), catalase, and superoxide dismutase (SOD) in the plasma and erythrocytes. Levels of total thiols, reduced glutathione (GSH), total antioxidant status (TAS), hydrogen peroxide, ascorbic acid, iron, and protein sulfhydryls were determined using spectrophotometry. We also evaluated the level of nitric oxide (NO) and peroxynitrite in plasma from COPD patients and healthy controls. Estimation of DNA damage was determined using the comet assay. Pulmonary functional tests were performed by body plethysmography. Levels of MDA, PC, DNA damage, and AOPP were significantly increased while total thiols, GSH, and TAS were decreased in COPD patients. GSH-Px activity was higher in COPD patients while no difference was found for catalase and SOD. We also observed a lower level of NO and peroxynitrite in COPD patients. Decreased levels of peroxynitrite were found to correlate with disease progression, as well as with forced expiratory volume in 1 s/forced vital capacity among COPD patients. Multivariate analysis revealed that NO is associated with pathological pathways that help to predict patient outcome independently of the degree of airflow obstruction. These results indicate the presence of a systemic oxidative stress and highlight the importance of NO and peroxynitrite as major effectors in COPD development and airflow obstruction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

AOPP:

Advanced oxidation protein products

BMI:

Body mass index

CAT:

Catalase

COPD:

Chronic obstructive pulmonary disease

FEV1%:

Forced expiratory volume in 1 s (%predicted)

FVC:

Forced vital capacity

GOLD:

Global Initiative for Chronic Obstructive Lung Disease

GSH:

Glutathione

GSH-Px:

Glutathione peroxydase

MDA:

Malondialdehyde

NO:

Nitric oxide

PC:

Protein carbonyls

RNS:

Reactive nitrogen species

ROS:

Reactive oxygen species

SOD:

Superoxide dismutase

TAS:

Total antioxidant status

TBA:

Thiobarbituric acid

References

  1. Angelis N, Porpodis K, Zarogoulidis P et al (2014) Airway inflammation in chronic obstructive pulmonary disease. J Thorac Dis. doi:10.3978/j.issn.2072-1439.2014.03.07

    Google Scholar 

  2. Gumral N, Naziroglu M, Ongel K et al (2009) Antioxidant enzymes and melatonin levels in patients with bronchial asthma and chronic obstructive pulmonary disease during stable and exacerbation periods. Cell Biochem Funct 27:276–83

    Article  PubMed  CAS  Google Scholar 

  3. Antus B, Harnasi G, Drozdovszky O, Barta I (2014) Monitoring oxidative stress during chronic obstructive pulmonary disease exacerbations using malondialdehyde. Respirology 19:74–9

    Article  PubMed  Google Scholar 

  4. Tanrikulu AC, Abakay A, Evliyaoglu O, Palanci Y (2011) Coenzyme Q10, copper, zinc, and lipid peroxidation levels in serum of patients with chronic obstructive pulmonary disease. Biol Trace Elem Res 143:659–67

    Article  PubMed  CAS  Google Scholar 

  5. Griffiths HR, Dias IH, Willetts RS, Devitt A (2014) Redox regulation of protein damage in plasma. Redox Biol 2:430–5

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  6. Torres-Ramos YD, García-Guillen ML, Olivares-Corichi IM, Hicks JJ (2009) Correlation of plasma protein carbonyls and C-reactive protein with GOLD stage progression in COPD patients. Open Respir Med J. doi:10.2174/1874306400903010061

    PubMed  PubMed Central  Google Scholar 

  7. Corradi M, Majori M, Cacciani GC, Consigli GF, de’Munari E, Pesci A (1999) Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease. Thorax 54:572–5

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  8. Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA, Barnes PJ (1998) Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:998–1002

    Article  PubMed  CAS  Google Scholar 

  9. Rutgers SR, van der Mark TW, Coers W et al (1999) Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease. Thorax 54:576–80

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  10. Ahmad A, Shameem M, Husain Q (2013) Altered oxidant–antioxidant levels in the disease prognosis of chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 17:1104–9

    Article  PubMed  CAS  Google Scholar 

  11. Santos MC, Oliveira AL, Viegas-Crespo AM et al (2004) Systemic markers of the redox balance in chronic obstructive pulmonary disease. Biomarkers 9:461–9

    Article  PubMed  CAS  Google Scholar 

  12. Kluchová Z, Petrásová D, Joppa P, Dorková Z, Tkácová R (2007) The association between oxidative stress and obstructive lung impairment in patients with COPD. Physiol Res 56:51–6

    PubMed  Google Scholar 

  13. Nowak D, Kasielski M, Antczak A, Pietras T, Bialasiewicz P (1999) Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med 93:389–96

    Article  PubMed  CAS  Google Scholar 

  14. Nadeem A, Raj HG, Chhabra SK (2005) Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease. Inflammation 29:23–32

    Article  PubMed  CAS  Google Scholar 

  15. Rahman I, Swarska E, Henry M, Stolk J, MacNee W (2000) Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease? Thorax 55:189–93

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  16. Draper HH, Hadley M (1990) Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186:421–31

    Article  PubMed  CAS  Google Scholar 

  17. Reznick AZ, Packer L (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233:357–63

    Article  PubMed  CAS  Google Scholar 

  18. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C et al (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304–13

    Article  PubMed  CAS  Google Scholar 

  19. Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 25:192–205

    Article  PubMed  CAS  Google Scholar 

  20. Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR (1974) Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11:151–69

    Article  PubMed  CAS  Google Scholar 

  21. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG (1973) Selenium: biochemical role as a component of glutathione peroxidase. Science 179:588–90

    Article  PubMed  CAS  Google Scholar 

  22. Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–6

    Article  PubMed  CAS  Google Scholar 

  23. Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469–74

    Article  PubMed  CAS  Google Scholar 

  24. Wolff SP (1994) Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxide. Methods Enzymol 233:182–189

    Article  CAS  Google Scholar 

  25. Jagota SK, Dani HM (1982) A new colorimetric technique for the estimation of vitamin C using Folin phenol reagent. Anal Biochem 127:178–82

    Article  PubMed  CAS  Google Scholar 

  26. Gay C, Collins J, Gebicki JM (1999) Determination of iron in solutions with the ferric-xylenol orange complex. Anal Biochem 273:143–8

    Article  PubMed  CAS  Google Scholar 

  27. Arif E, Ahsan A, Vibhuti A et al (2007) Endothelial nitric oxide synthase gene variants contribute to oxidative stress in COPD. Biochem Biophys Res Commun 361:182–8

    Article  PubMed  CAS  Google Scholar 

  28. VanUffelen BE, Van der Zee J, deKoster BM, VanStereninck J, Elferink JG (1998) Intracellular but not extracellular conversion of nitroxyl anion into nitric oxide leads to stimulation of human neutrophil migration. Biochem J 330:719–722

    PubMed  CAS  PubMed Central  Google Scholar 

  29. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C (1999) Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 26:1231–7

    Article  PubMed  CAS  Google Scholar 

  30. Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184–91

    Article  PubMed  CAS  Google Scholar 

  31. Akkuş S, Naziroğlu M, Eriş S, Yalman K, Yilmaz N, Yener M (2009) Levels of lipid peroxidation, nitric oxide, and antioxidant vitamins in plasma of patients with fibromyalgia. Cell Biochem Funct 27:181–5

    Article  PubMed  Google Scholar 

  32. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A (2006) Biomarkers of oxidative damage in human disease. Clin Chem 52:601–23

    Article  PubMed  CAS  Google Scholar 

  33. Alderman CJ, Shah S, Foreman JC, Chain BM, Katz DR (2002) The role of advanced oxidation protein products in regulation of dendritic cell function. Free Radic Biol Med 32:377–85

    Article  PubMed  CAS  Google Scholar 

  34. Çalikoglu M, Tamer L, ÇaIkoglu I, AtI S, Uluba B, Ercan B (2002) Oxidative stress and products of nitric oxide metabolism in chronic obstructive pulmonary disease and in healthy smokers. Turk Resp J 3:24–7

    Google Scholar 

  35. Dinh-Xuan AT, Higenbottam TW, Clelland CA et al (1991) Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl JMed 324:1539–47

    Article  CAS  Google Scholar 

  36. Assreuy J, Cunha FQ, Liew FY, Moncada S (1993) Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol 108:833–7

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  37. Prado CM, Leick-Maldonado EA, Yano L et al (2006) Effects of nitric oxide synthases in chronic allergic airway inflammation and remodeling. Am J Respir Cell. Mol Biol 35:457–65

    CAS  Google Scholar 

  38. Clini E, Cremona G, Campana M et al (2000) Production of endogenous nitric oxide in chronic obstructive pulmonary disease and patients with cor pulmonale. Correlates with echo-Doppler assessment. Am J Respir Crit Care Med 162:446–50

    Article  PubMed  CAS  Google Scholar 

  39. Casey DB, Pankey EA, Badejo AM et al (2012) Peroxynitrite has potent pulmonary vasodilator activity in the rat. Can J Physiol Pharmacol 90:485–500

    Article  PubMed  CAS  Google Scholar 

  40. Chabot F, Mitchell JA, Quinlan GJ, Evans TW (1997) Characterization of the vasodilator properties of peroxynitrite on rat pulmonary artery: role of poly (adenosine 5′-diphosphoribose) synthase. Br J Pharmacol 121:485–90

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Acknowledgments

This work was supported by the Ministry of Higher Education and Scientific Research and by the Ministry of Public Health of the Tunisian Government. We would like to thank Pr Saloua Abid (Laboratory of Research on Biologically Compatible Compounds, Faculty of Dentistry, Monastir University, Tunisia) and Dr Ghada ben Salah (Laboratory of Human Molecular Genetics, Faculty of Médicine, Sfax, Tunisia) for their help in the realization of the comet test.

Conflict of interest

The authors declare that they have no competing interests.

Author’s contributions

BAA (PhD) carried out the different experiments and drafted the manuscript; FH (Associate Professor), BNH (Assistant, PhD), CE (MD, PhD), BS (thesis student), and CH (thesis student) participated in the measurement of the different parameters related to the oxidant–antioxidant status; YS (MD, Professor), GA (MD, Professor), BM (MD, Professor), and TZ (MD, PhD, Professor) participated in the design of the study and coordination and helped to draft the manuscript; CK (PhD, Professor) participated in the different experiments, in the design of the study and to draft the manuscript. All authors read and approved the final manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karim Chahed.

Additional information

Summary at a Glance: This study provides a strong evidence for altered oxidant–antioxidant balance in the plasma from Tunisian patients with COPD. Our findings also point out the relevance of nitric oxide and peroxynitrite as major effectors in COPD development and airflow obstruction.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ben Anes, A., Fetoui, H., Bchir, S. et al. Increased Oxidative Stress and Altered Levels of Nitric Oxide and Peroxynitrite in Tunisian Patients with Chronic Obstructive Pulmonary Disease: Correlation with Disease Severity and Airflow Obstruction. Biol Trace Elem Res 161, 20–31 (2014). https://doi.org/10.1007/s12011-014-0087-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-014-0087-4

Keywords

Navigation